v3.21.2
Revenue (Tables)
9 Months Ended
Oct. 01, 2021
Revenue [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments The Company’s Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment for use in cutting, joining and automated welding, as well as gas control equipment. Substantially all revenue from the Fabrication Technology business is recognized at a point in time. The Company disaggregates its Fabrication Technology revenue into the following product groups:
Three Months EndedNine Months Ended
October 1, 2021October 2, 2020October 1, 2021October 2, 2020
(In thousands)
Equipment$192,365 $157,730 $564,971 $443,563 
Consumables413,603 333,767 1,238,929 987,838 
Total$605,968 $491,497 $1,803,900 $1,431,401 

Contracts with customers in the consumables product grouping generally have a shorter fulfillment period than equipment contracts.

The Company’s Medical Technology segment provides products and services spanning the orthopedic continuum of patient care, from injury prevention to rehabilitation. While the Company’s Medical Technology sales are primarily derived from three sales channels including dealers and distributors, insurance, and direct to consumers and hospitals, substantially all its revenue is recognized at a point in time.

The Company disaggregates its Medical Technology revenue into the following product groups:
Three Months EndedNine Months Ended
October 1, 2021October 2, 2020October 1, 2021October 2, 2020
(In thousands)
Prevention & Recovery(1)
$260,001 $242,591 $765,207 $626,227 
Reconstructive99,922 71,843 261,923 185,019 
Total$359,923 $314,434 $1,027,130 $811,246 
(1) For the periods presented, the Prevention & Recovery product group includes bone growth stimulation products, which were previously classified as part of the Reconstructive product group.
Financing Receivable, Allowance for Credit Loss
A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Condensed Consolidated Balance Sheets is as follows:
Nine Months Ended October 1, 2021
Balance at
Beginning
of Period
Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation
Balance at
End of
Period
(In thousands)
Allowance for credit losses$37,666 $(17)$(2,194)$(778)$34,677